Celsion, an oncology drug development company, spoke in detail about a development that could play greatly into the studies of brain cancer. It would set its sights primarily on glioblastoma, which is understandable when given the details. Often regarded as the most aggressive form of cancer in the brain, it's not hard to see why this is such a big focus. That being said, is it possible that a new approach can be put to use in order to help patients who have been impacted by the condition in question?
It seems like there is the possibility for this to happen, as an article on Pharmaceutical Business Review detailed. With a certain approach brought into effect, the goal is to help treat tumors in the brain, with glioblastoma being the primary focus. While it's clear that this ailment has been given focus by organizations such as Voices against Brain Cancer, one has to wonder what exactly this approach entails. There are a couple of elements that can help to bring this approach together and allow it to be successful.
The company will put forth experiments that will determine the effectiveness of ThermoDox in conjunction with MR guided high intensity focused ultrasound. The focus will be placed on animal models first before, if successful, being parlayed into human use. According to Dr. Nicholas Borys, ThermoDox is a "heat-activated liposomal encapsulation of doxorubicin," which would be able to provide clinical benefit. It has also been utilized for the sake of treating other types of cancer, which lends credence to the idea that it could come into play in this field as well.
The report also detailed a phase III HEAT study that could, in theory, prove the effectiveness of ThermoDox along with RFA. Would patients be able to react positively to this combination, one would have to wonder? After the results were found, it was determined that ThermoDox could prove to be useful for the sake of improving PFS degrees. Seeing as how survival rates could be made greater for patients stricken with cancer, to say that results can stand to be great would be an understatement.
Who is it to say that these results couldn't come into play for future results, either? I have to believe that there is more with the ThermoDox approach than what has been seen already; why else would it have such a great deal of focus placed on it? With its usage in other types of cancer, it seems as though potential results can be found in the way of brain cancer as well. It's just a matter of making sure that the best strategies are seen and carried out.
It seems like there is the possibility for this to happen, as an article on Pharmaceutical Business Review detailed. With a certain approach brought into effect, the goal is to help treat tumors in the brain, with glioblastoma being the primary focus. While it's clear that this ailment has been given focus by organizations such as Voices against Brain Cancer, one has to wonder what exactly this approach entails. There are a couple of elements that can help to bring this approach together and allow it to be successful.
The company will put forth experiments that will determine the effectiveness of ThermoDox in conjunction with MR guided high intensity focused ultrasound. The focus will be placed on animal models first before, if successful, being parlayed into human use. According to Dr. Nicholas Borys, ThermoDox is a "heat-activated liposomal encapsulation of doxorubicin," which would be able to provide clinical benefit. It has also been utilized for the sake of treating other types of cancer, which lends credence to the idea that it could come into play in this field as well.
The report also detailed a phase III HEAT study that could, in theory, prove the effectiveness of ThermoDox along with RFA. Would patients be able to react positively to this combination, one would have to wonder? After the results were found, it was determined that ThermoDox could prove to be useful for the sake of improving PFS degrees. Seeing as how survival rates could be made greater for patients stricken with cancer, to say that results can stand to be great would be an understatement.
Who is it to say that these results couldn't come into play for future results, either? I have to believe that there is more with the ThermoDox approach than what has been seen already; why else would it have such a great deal of focus placed on it? With its usage in other types of cancer, it seems as though potential results can be found in the way of brain cancer as well. It's just a matter of making sure that the best strategies are seen and carried out.
About the Author:
If you'd care for further information regarding glioblastoma, please consult Voices against Brain Cancer.. This article, Can A Particular Development Program Help Glioblastoma? is released under a creative commons attribution license.
No comments:
Post a Comment